Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer
Xiangfeng Shen(First Bethune Hospital of Jilin University), Zhixiang Xu(University of Electronic Science and Technology of China), Yuan Zhao(Henan University), Lihong Zhang(Jilin University), Yishu Wang(Jilin University), Hong-Lan Zhou(First Hospital of Jilin University), Jiyong Liang(The University of Texas MD Anderson Cancer Center), Jingjing Fan(Xinjiang Medical University), Yulin Li(Ministry of Education of the People's Republic of China), Guolong Liu(South China University of Technology)
Cited by 34
Related Papers
Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13
|Cell|2011|817
Spermidine coupled with exercise rescues skeletal muscle atrophy from D-gal-induced aging rats through enhanced autophagy and reduced apoptosis via AMPK-FOXO3a signal pathway
|Oncotarget|2017|177
Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillance
|Nature Communications|2015|141
Recent advances in metal/covalent organic framework-based materials for photoelectrochemical sensing applications
|TrAC Trends in Analytical Chemistry|2022|133
Recent Findings in the Regulation of Programmed Death Ligand 1 Expression
|Frontiers in Immunology|2019|132